Valneva SE
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Valneva is a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical need. The Company has several vaccines in development, including unique vaccines against Lyme disease, COVID-19 and chikungunya. Valneva’s portfolio also includes two commercial vaccines for travelers.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-05 17:45 |
Earnings Release
Valneva annonce des résultats positifs de Phase 2 à six mois sur la persistance…
|
French | 236.5 KB | |
| 2025-06-05 17:45 |
Earnings Release
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Resu…
|
English | 178.3 KB | |
| 2025-06-05 07:30 |
Declaration of Voting Results & Voting Rights Announcements
[Valneva SE] Déclaration d’actions et de droits de vote - mai 2025
|
French | 160.2 KB | |
| 2025-06-05 07:30 |
Declaration of Voting Results & Voting Rights Announcements
[Valneva SE] Declaration of shares and voting rights - May 2025
|
English | 170.0 KB | |
| 2025-06-04 07:00 |
General Meeting Notice
Valneva annonce la mise à disposition des documents préparatoires à son Assembl…
|
French | 115.0 KB | |
| 2025-06-04 07:00 |
Regulatory News Service
Valneva Announces Availability of Documentation for its Combined Shareholder Me…
|
English | 122.8 KB | |
| 2025-05-26 17:30 |
Regulatory News Service
Valneva participera à différentes conférences d’investisseurs aux États-Unis et…
|
French | 150.8 KB | |
| 2025-05-26 17:30 |
Regulatory News Service
Valneva to Participate at U.S. and European Investor Conferences in June
|
English | 120.9 KB | |
| 2025-05-12 07:00 |
Regulatory News Service
Valneva fait un point sur les recommandations d’utilisation d'IXCHIQ® chez les …
|
French | 163.7 KB | |
| 2025-05-12 07:00 |
Regulatory News Service
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in…
|
English | 138.7 KB | |
| 2025-05-07 18:00 |
Declaration of Voting Results & Voting Rights Announcements
VALNEVA Declaration of shares and voting rights: April 30, 2025
|
English | 14.2 KB | |
| 2025-05-07 18:00 |
Declaration of Voting Results & Voting Rights Announcements
VALNEVA Déclaration d’actions et de droits de vote : 30 avril 2025
|
French | 14.5 KB | |
| 2025-05-07 17:45 |
Regulatory News Service
Valneva fait un point suite à l'annonce de l'agence européenne des médicaments …
|
French | 160.3 KB | |
| 2025-05-07 17:45 |
Regulatory News Service
Valneva Provides Update Following European Medicines Agency Announcement on Use…
|
English | 173.0 KB | |
| 2025-05-07 07:00 |
Earnings Release
Valneva Reports First Quarter 2025 Financial Results and Provides Corporate Up…
|
English | 385.0 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Rekah Pharmaceutical Prod Ltd. | Israel | REKA | |
|
RELIEF Therapeutics Holding AG | Switzerland | RLF | |
|
Replek AD | North Macedonia | REPL | |
|
Roche Holding AG | Switzerland | RO | |
|
Ropharma S.A. | Romania | RPH | |
|
RYVU Therapeutics S.A. | Poland | RVU | |
|
Sano Bruno's Enterprises Ltd. | Israel | SANO1 | |
|
Sanofi | France | SAN | |
|
Santhera Pharmaceuticals Holding AG | Switzerland | SANN | |
|
Schott Pharma | Germany | 1SXP |